-
-
-
-
-
-
-
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience
-
-
-
-
-
-
-
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
-
-
-
-
-
-
-
MediPharm Labs Sets Date to Report First Quarter 2025 Financial Results
-
-
-
-
-
-
-
MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil
-
-
-
-
-
-
-
/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/
-
-
-
-
-
-
-
MediPharm Labs Reports Fourth Quarter and Full Year Results
-
-
-
-
-
-
-
MediPharm Labs Settles an Outstanding Claim for $9M
-
1,201,290 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


